Physician profile
Donna D Elia
NPI 1518039981
$8,715.01
in general payments reported to CMS, 2019-2025
37 companies · $422 in 2025
The $422 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $1,518 · 2021: $651 · 2022: $3,870 · 2023: $740 · 2024: $562 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.58 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $3,150.00 | 2022 | |
| Boston Scientific Corporation | $1,084.97 | 2020 | |
| Amgen INC. | $862.33 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $537.50 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $505.15 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $379.04 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $373.96 | 2023-2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $205.30 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $170.92 | 2022-2025 | |
| Exeltis, USA INC. | $130.31 | 2019-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $126.97 | 2019-2025 | |
| Exact Sciences Corporation | $96.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $95.73 | 2021-2022 | |
| Coopersurgical, INC. | $93.25 | 2023-2025 | Endosee, Paragard T 380a |
| Evofem Biosciences, INC. | $86.52 | 2021-2025 | Solosec, Phexx, Phexxi |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $80.78 | 2019-2020 | |
| Allergan, INC. | $76.60 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $75.96 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $68.08 | 2019-2024 | Gardasil, Gardasil 9 |
| Organon LLC | $57.83 | 2021-2023 | Nexplanon |
| Daiichi Sankyo INC. | $54.70 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $51.70 | 2019-2022 | |
| Hologic Sales and Service, LLC | $51.25 | 2019-2024 | Acessa Provu System |
| Avion Pharmaceuticals | $40.87 | 2019-2021 | |
| Mission Pharmacal Company | $36.93 | 2019 | |
| Covidien LP | $36.91 | 2019 | |
| Millicent US INC | $32.17 | 2019-2024 | Intrarosa, Femring |
| Medicem INC. | $20.71 | 2023 | |
| Medtronic, INC. | $20.41 | 2022 | |
| Becton, Dickinson and Company | $19.85 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.34 | 2025 | |
| Antares Pharma, INC. | $14.87 | 2022 | |
| Novo Nordisk INC | $13.65 | 2020 | |
| Duchesnay USA Incorporated | $12.40 | 2019 | |
| Radius Health, INC. | $11.93 | 2019 | |
| Scynexis, INC. | $11.73 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna D Elia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.